The Advances in nanostructures vaccine, new approaches to improve for anticancer and immune system efficiency

Advances in nanostructures vaccine, new approaches to improve for anticancer and immune system efficiency

  • NEGAR JAVANMARDI 1. School of Chemistry and Chemical Engineering. Nanjing University of Science and Technology.
  • Zahra Javidi Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Sargol Mazraedoost Department of Civil Engineering, Sirjan University of Technology, Kerman, Iran.
  • Yekta Omidi Dentist, Shiraz Dental School, Shiraz University of Medical sciences, Shiraz Iran
  • Amir Hashemi Hosseini Dentist, Shiraz Dental School, Shiraz University of Medical sciences, Shiraz Iran
  • Marzie Mokhberi Dentist, Shiraz Dental School, Shiraz University of Medical sciences, Shiraz Iran
Keywords: Nano vaccine, Drug delivery, Anti-Cancer, Nanoparticles, Delivery of antigen, Immune system




Download data is not yet available.


Doll, T.A., et al., Nanoscale assemblies and their biomedical applications. Journal of The Royal Society Interface, 2013. 10(80): p. 20120740.
2. Latham, T. and J.M. Galarza, Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. Journal of virology, 2001. 75(13): p. 6154-6165.
3. Kaba, S.A., et al., A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria. The Journal of Immunology, 2009. 183(11): p. 7268-7277.
4. Marrack, P., A.S. McKee, and M.W. Munks, Towards an understanding of the adjuvant action of aluminium. Nature Reviews Immunology, 2009. 9(4): p. 287-293.
5. Daftarian, P., et al., Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion. Vaccine, 2006. 24(24): p. 5235-5244.
6. Ishii, K.J. and S. Akira, Toll or toll-free adjuvant path toward the optimal vaccine development. Journal of clinical immunology, 2007. 27(4): p. 363-371.
7. Maraskovsky, E., et al., Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant. Immunology and cell biology, 2009. 87(5): p. 371-376.
8. Sun, H.-X., Y. Xie, and Y.-P. Ye, Advances in saponin-based adjuvants. Vaccine, 2009. 27(12): p. 1787-1796.
9. Bettahi, I., et al., Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes. Cancer immunology, immunotherapy, 2009. 58(2): p. 187.
10. Toth, I., P. Simerska, and Y. Fujita, Recent advances in design and synthesis of self-adjuvanting lipopeptide vaccines. International Journal of Peptide Research and Therapeutics, 2008. 14(4): p. 333-340.
11. Rudra, J.S., et al., A self-assembling peptide acting as an immune adjuvant. Proceedings of the National Academy of Sciences, 2010. 107(2): p. 622-627.
12. Chai, S., et al., Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes. The Journal of Immunology, 1992. 149(7): p. 2385-2390.
13. Aranda, F., et al., Trial Watch: Peptide vaccines in cancer therapy. Oncoimmunology, 2013. 2(12): p. e26621.
14. Robinson-Smith, T.M., et al., Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer research, 2007. 67(12): p. 5708-5716.
15. Luo, Z., et al., Nanovaccine loaded with poly I: C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo. Biomaterials, 2015. 38: p. 50-60.
16. Hargadon, K.M., Tumor-altered dendritic cell function: implications for anti-tumor immunity. Frontiers in immunology, 2013. 4: p. 192.
17. Goldberg, M.S., Immunoengineering: how nanotechnology can enhance cancer immunotherapy. Cell, 2015. 161(2): p. 201-204.
18. Hajizade, A., et al., Nanoparticles in vaccine development. Journal of Applied Biotechnology Reports, 2014. 1(4): p. 125-134.
19. Zhuang, Y., et al., PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution. Journal of Controlled Release, 2012. 159(1): p. 135-142.
20. Luo, Z., et al., Cationic polypeptide micelle-based antigen delivery system: a simple and robust adjuvant to improve vaccine efficacy. Journal of Controlled Release, 2013. 170(2): p. 259-267.
21. Hirosue, S., et al., Antigen delivery to dendritic cells by poly (propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation. Vaccine, 2010. 28(50): p. 7897-7906.
22. Li, P., et al., Bioreducible alginate-poly (ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses. Journal of Controlled Release, 2013. 168(3): p. 271-279.
23. Liu, Q., et al., pH-responsive poly (D, L-lactic-co-glycolic acid) nanoparticles with rapid antigen release behavior promote immune response. ACS nano, 2015. 9(5): p. 4925-4938.
24. Wang, C., et al., Self-adjuvanted nanovaccine for cancer immunotherapy: Role of lysosomal rupture-induced ROS in MHC class I antigen presentation. Biomaterials, 2016. 79: p. 88-100.
25. Palmer, K., et al., Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity. Gene Therapy, 2001. 8(4): p. 282-290.
26. Bonifaz, L., et al., Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. Journal of Experimental Medicine, 2002. 196(12): p. 1627-1638.
27. Xing, Z., et al., Recent advances in the development of adenovirus-and poxvirus-vectored tuberculosis vaccines. Current gene therapy, 2005. 5(5): p. 485-492.
28. Zhang, R., M.M. Billingsley, and M.J. Mitchell, Biomaterials for vaccine-based cancer immunotherapy. Journal of Controlled Release, 2018. 292: p. 256-276.
29. Wang, R.-F. and H.Y. Wang, Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells. Nature biotechnology, 2002. 20(2): p. 149-154.
30. Mahnke, K., et al., Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice. Cancer Research, 2005. 65(15): p. 7007-7012.
31. Chesson, C.B., et al., Antigenic peptide nanofibers elicit adjuvant-free CD8+ T cell responses. Vaccine, 2014. 32(10): p. 1174-1180.
32. Chen, F.-M. and X. Liu, Advancing biomaterials of human origin for tissue engineering. Progress in polymer science, 2016. 53: p. 86-168.
33. Rajendrakumar, S.K., et al., Self-assembled, adjuvant/antigen-based nanovaccine mediates anti-tumor immune response against melanoma tumor. Polymers, 2018. 10(10): p. 1063.
34. Timmerman, J.M., et al., Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood, The Journal of the American Society of Hematology, 2002. 99(5): p. 1517-1526.
35. Eskandari, S., et al., Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering. Advanced drug delivery reviews, 2017. 110: p. 169-187.
36. Aguilar, J. and E. Rodriguez, Vaccine adjuvants revisited. Vaccine, 2007. 25(19): p. 3752-3762.
37. Gupta, R.K., Aluminum compounds as vaccine adjuvants. Advanced drug delivery reviews, 1998. 32(3): p. 155-172.
38. Huntimer, L., et al., Evaluation of biocompatibility and administration site reactogenicity of polyanhydride‐particle‐based platform for vaccine delivery. Advanced healthcare materials, 2013. 2(2): p. 369-378.
39. Chong, C.S., et al., Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. Journal of controlled release, 2005. 102(1): p. 85-99.
40. Fehres, C.M., et al., Understanding the biology of antigen cross-presentation for the design of vaccines against cancer. Frontiers in immunology, 2014. 5: p. 149.
41. Mousavi, S.M., et al., Development of hydrophobic reduced graphene oxide as a new efficient approach for photochemotherapy. RSC Advances, 2020. 10(22): p. 12851-12863.
42. Chen, D.S. and I. Mellman, Oncology meets immunology: the cancer-immunity cycle. immunity, 2013. 39(1): p. 1-10.
43. Melero, I., et al., Therapeutic vaccines for cancer: an overview of clinical trials. Nature reviews Clinical oncology, 2014. 11(9): p. 509-524.
44. Zhu, G., et al., Efficient nanovaccine delivery in cancer immunotherapy. ACS nano, 2017. 11(3): p. 2387-2392.
45. Zhang, Z., et al., Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery. Biomaterials, 2011. 32(14): p. 3666-3678.
46. Azmi, F., et al., Recent progress in adjuvant discovery for peptide-based subunit vaccines. Human vaccines & immunotherapeutics, 2014. 10(3): p. 778-796.
47. Hashemi, S.A., et al., Coupled graphene oxide with hybrid metallic nanoparticles as potential electrochemical biosensors for precise detection of ascorbic acid within blood. Analytica chimica acta, 2020. 1107: p. 183-192.
48. Clawson, C., et al., Delivery of a peptide via poly (d, l-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell–stimulatory capacity. Nanomedicine: Nanotechnology, Biology and Medicine, 2010. 6(5): p. 651-661.
49. Zhang, Y., et al., Nanovaccines for cancer immunotherapy. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2019. 11(5): p. e1559.
50. Cheung, A.S. and D.J. Mooney, Engineered materials for cancer immunotherapy. Nano today, 2015. 10(4): p. 511-531.
51. Hashemi, S.A., et al., Integrated polyaniline with graphene oxide-iron tungsten nitride nanoflakes as ultrasensitive electrochemical sensor for precise detection of 4-nitrophenol within aquatic media. Journal of Electroanalytical Chemistry, 2020. 873: p. 114406.
52. Hailemichael, Y., et al., Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion. Nature medicine, 2013. 19(4): p. 465-472.
53. Reddy, S.T., et al., Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nature biotechnology, 2007. 25(10): p. 1159-1164.
54. Gelain, F., A. Horii, and S. Zhang, Designer self‐assembling peptide scaffolds for 3‐D tissue cell cultures and regenerative medicine. Macromolecular bioscience, 2007. 7(5): p. 544-551.
55. Fifis, T., et al., Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. The Journal of Immunology, 2004. 173(5): p. 3148-3154.
56. Mottram, P.L., et al., Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Molecular pharmaceutics, 2007. 4(1): p. 73-84.
57. S.M. Mousavi, et al., Recent Biotechnological Approaches for Treatment of Novel COVID-19: From Bench to Clinical Trial.2021, Drug Metabolism Reviews

58. SA Hashemi., et al., Ultra-sensitive viral glycoprotein detection NanoSystem toward accurate tracing SARS-CoV-2 in biological/non-biological media. 2021, Biosensors and Bioelectronics.
59. S.M. Mousavi, S. Soroshnia, S.A. Hashemi, A. Babapoor, Y. Ghasemi, A. Savardashtaki, A.M. Amani, Graphene nano-ribbon based high potential and efficiency for DNA, cancer therapy and drug delivery applications, Drug metabolism reviews 51(1) (2019) 91-104.
60. Abdollahifar, A., et al., Electromagnetic interference shielding effectiveness of reinforced composite with graphene oxide-lead oxide hybrid nanosheets. Radiation Effects and Defects in Solids, 2019. 174(9-10): p. 885-898.
61. Mousavi, M., et al., Erythrosine adsorption from aqueous solution via decorated graphene oxide with magnetic iron oxide nano particles: kinetic and equilibrium studies. Acta Chimica Slovenica, 2018. 65(4): p. 882-894.
62. Abdollahifar, A., et al., Fabrication of graphene oxide‐lead oxide epoxy based composite with enhanced chemical resistance, hydrophobicity and thermo‐mechanical properties. Advances in Polymer Technology, 2018. 37(8): p. 3792-3803.
63. Monfared, M., et al., Emerging frontiers in drug release control by core–shell nanofibers: A review. Drug metabolism reviews, 2019. 51(4): p. 589-611.
64. Mousavi, S.M., et al., Octadecyl amine functionalized Graphene oxide towards hydrophobic chemical resistant epoxy Nanocomposites. ChemistrySelect, 2018. 3(25): p. 7200-7.
65. Mousavi, S.M., et al., Graphene nano-ribbon based high potential and efficiency for DNA, cancer therapy and drug delivery applications. Drug metabolism reviews, 2019. 51(1): p. 91-104.
66. Hashemi, S.A., et al., Lead oxide-decorated graphene oxide/epoxy composite towards X-Ray radiation shielding. Radiation Physics and Chemistry, 2018. 146: p. 77-85.
67. Mousavi, S.M., et al., Applications of graphene oxide in case of nanomedicines and nanocarriers for biomolecules: review study. Drug metabolism reviews, 2019. 51(1): p. 12-41.
68. Avval, Z.M., et al., Introduction of magnetic and supermagnetic nanoparticles in new approach of targeting drug delivery and cancer therapy application. Drug metabolism reviews, 2020. 52(1): p. 157-184.
69. Mousavi, S.M., et al., Modification of phenol novolac epoxy resin and unsaturated polyester using sasobit and silica nanoparticles. Polymers from Renewable Resources, 2017. 8(3): p. 117-132.
70. Mousavi, S.M., et al., A conceptual review of rhodanine: current applications of antiviral drugs, anticancer and antimicrobial activities. Artificial cells, nanomedicine, and biotechnology, 2019. 47(1): p. 1132-1148.
71. Mousavi, S.M., et al., Development of clay nanoparticles toward bio and medical applications. 2018: IntechOpen.
72. Zakeri, A., et al., Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon. Nano reviews & experiments, 2018. 9(1): p. 1488497.
73. Ravanshad, R., et al., Application of nanoparticles in cancer detection by Raman scattering based techniques. Nano reviews & experiments, 2018. 9(1): p. 1373551.
74. Mousavi, S.M., et al., Development of graphene based nanocomposites towards medical and biological applications. Artificial cells, nanomedicine, and biotechnology, 2020. 48(1): p. 1189-1205.
75. Mousavi SM, Zarei M, Hashemi SA, Ramakrishna S, Chiang W-H, Lai CW, et al. Gold nanostars-diagnosis, bioimaging and biomedical applications. Drug Metabolism Reviews. 2020;52:299-318.
How to Cite
JAVANMARDI N, Javidi Z, Mazraedoost S, Omidi Y, Hashemi Hosseini A, Mokhberi M. The Advances in nanostructures vaccine, new approaches to improve for anticancer and immune system efficiency. AANBT [Internet]. 5Oct.2021 [cited 4Oct.2022];2(4):102-11. Available from: